Initial claims for regular state unemployment insurance jumped by 17,000 for the week ending November 19th, coming in at 240,000. The previous
The final November results from the University of Michigan Surveys of Consumers show overall consumer sentiment declined for the month, holding near
Alesia Haas – the Chief Financial Officer of Coinbase Global Inc (NASDAQ: COIN) once agreed to at least a “small risk of
The Biden administration has launched a full-scale economic offensive against China. Although the US has the stronger, more-advanced economy, victory will come
The 40-year MNO lock-in is broken, as power switches to the hands of the enterprise, and proprietary relationships become a challenge of
David Einhorn needs no introduction as he is one of Wall Street’s most famous investors. He is not afraid of making bold
Core Scientific (NASDAQ: CORZ), a publicly traded crypto miner that’s facing increased possibility of bankruptcy, has revealed a $434 million loss for
News that The Walt Disney Corporation’s former CEO, Robert Iger, would return to the helm of the firm surprised Wall Street, Disney
The energy crisis in Europe continues to draw division among EU member states regarding the best way to address it. Some members
Bitcoin (BTC/USD) traded above $16,000 on Wednesday morning, rising by about 3.2% at the time of writing to hover just above $16,500. Despite
Reprinted from the James G. Martin Center for Academic Renewal Many people believe that if a college or university is accredited, that’s the
Healthcare providers are always pushing innovation to stay on the cutting edge of their industry. Quickly embracing technology that could provide improved
Glencore (LON: GLEN) share price held steady on Wednesday after the embattled company sold an important business in Australia. The stock rose
Cathie Wood has made a name for herself as one of the most active and popular American investors in the technology sector.
Carvana (NYSE: CVNA) stock price has had a remarkable fall from grace as concern about the company continued. It plunged to a
“IBB” – the iShares Biotechnology ETF has already recovered about 30% over the past five months but Jefferies’ Michael Yee is convinced
